Competition affects who gets a liver transplantFox NewsWhen more than one center has patients on the same donor list, the centers have an incentive to get organs for as many of their own patients as possible, wrote researchers, whose report appeared in…
|
Orgenesis Announces Management Changes
MarketWatch (press release) The Company believes that converting the diabetic patient’s own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection. If successful, this could mean the end of diabetes, as we now know it. |
A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma …7thSpace Interactive (press release)She experienced a relapse 19 months later with involvement of the retroperitoneal lymph nodes, and commenced treatment with rituximab an…
|
Research and Markets: Biogen-Idec’s and Facet Biotech’s Daclizumab: Can It …
PharmiWeb.com (press release) Daclizumab is the active agent in Zenapax (Roche), a humanized antibody that blocks the IL-2 receptor. It was first approved in 1997 for transplant rejection prevention. A phase II study in multiple sclerosis (MS) showed evidence of activity and an … |
|
Research and Markets: Biogen-Idec’s and Facet Biotech’s Daclizumab: Can It …
Fort Mills Times Daclizumab is the active agent in Zenapax (Roche), a humanized antibody that blocks the IL-2 receptor. It was first approved in 1997 for transplant rejection prevention. A phase II study in multiple sclerosis (MS) showed evidence of activity and an … |
Research and Markets has announced the addition of the “Biogen-Idec’s and Facet Biotech’s Daclizumab: Can It Com
Times of IndiaSleep apnea may protect heart attack patientsTimes of IndiaBut findings of a new study carried out by scientists from Technion-Israel Institute of Technology have shown that some heart attack patients can actually benefit from mild to mod…
Immucor to AcquireLIFECODES BusinessPrivate Equity Hub (press release)The LIFECODES business specializes in pre-transplant human leukocyte antigen (HLA) typing and screening to ensure the most compatible match between patient and donor, as well as post…
Proteon reports positive results from PRT-201 Phase 2 trial in chronic kidney …Pharmaceutical Business ReviewProteon Therapeutics has reported positive results from Phase 2 trial of PRT-201 conducted in chronic kidney disease (CKD) patients undergoin…
|
Good for You in Martin County
TCPalm Martin County Tax Collector Ruth Pietruszewski and her staff were thanked by Donate Life on behalf of those whose lives were saved by organ donations. The office was awarded “Donor Designation Champion” for maintaining a 57 percent donor designation … |